Search research articles
Contact Us
Filters
Showing results (181-190 of 200) with videos related to
Page
of 20
Sort By:
The Lancet. Gastroenterology & Hepatology
|
June 3, 2019
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
Yong Lv, Zhiping Yang, Lei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 2, 2025
A Novel Score for Predicting Long-Term Outcomes in Recanalisation-Treated Patients With Budd-Chiari Syndrome: A Multicentre Study
Dongdong Xia, Bohan Luo, Qiuhe Wang, et al.
Investigational New Drugs
|
December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells
Jie Hu, Enxin Wang, Lei Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China
Dongdong Xia, Bohan Luo, Chunqing Zhang, et al.
Hepatology International
|
August 31, 2025
Management of acute variceal bleeding: updated APASL guidelines
Cosmas Rinaldi Adithya Lesmana, Akash Shukla, Ashish Kumar, et al.
Journal of Hepatology
|
January 28, 2021
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival
Dominik Bettinger, Lukas Sturm, Lena Pfaff, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Guohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 200) with videos related to
Sort By:
Page
of 20
The Lancet. Gastroenterology & Hepatology
|
June 3, 2019
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
Yong Lv, Zhiping Yang, Lei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 2, 2025
A Novel Score for Predicting Long-Term Outcomes in Recanalisation-Treated Patients With Budd-Chiari Syndrome: A Multicentre Study
Dongdong Xia, Bohan Luo, Qiuhe Wang, et al.
Investigational New Drugs
|
December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells
Jie Hu, Enxin Wang, Lei Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China
Dongdong Xia, Bohan Luo, Chunqing Zhang, et al.
Hepatology International
|
August 31, 2025
Management of acute variceal bleeding: updated APASL guidelines
Cosmas Rinaldi Adithya Lesmana, Akash Shukla, Ashish Kumar, et al.
Journal of Hepatology
|
January 28, 2021
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival
Dominik Bettinger, Lukas Sturm, Lena Pfaff, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Guohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Page
of 20